Related Experiment Video
Updated: Jan 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MiR-130a exerts neuroprotective effects against ischemic stroke through PTEN/PI3K/AKT pathway
Tingting Zheng1, Yu Shi1, Jun Zhang2
1Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Peking University Shenzhen Hospital, Shenzhen Peking University- The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong Province, PR China.
Background:
Ischemic stroke is significantly affected by the dysfunction of the miRNA network. Recent research has described that disordered expression of miR-130a is associated with ischemic stroke. Here, we aimed to investigate the possible mechanism of the miR-130a-mediated neuroprotection that follows ischemia-reperfusion (I/R) injury.
Method:
This study was comprised of two models: oxygen-glucose deprivation/Reperfusion (OGDR) and middle cerebral artery occlusion (MCAO). RT-PCR and immunoblotting were used to examine gene expression levels, and MTT assay and flow cytometric analysis were used to examine cell states. We also used 2, 3, 5-triphenyltetrazolium chloride (TTC) staining to assess the cerebral infarct volume. Then, we employed bioinformatics analysis and luciferase reporter assay to identify and validate the target molecule of miR-130a, PTEN.
Results:
Our findings indicated that miR-130a expression was lower in PC12 cells after OGDR (oxygen-glucose deprivation/reperfusion) and in rats after MCAO (middle cerebral artery occlusion). Moreover, ectopic-expression of miR-130a can significantly improve cell survival rate and reduce cell apoptosis and ROS production in PC12 cells after OGDR. In addition, re-expression of miR-130a yielded an obvious reduction in MCAO-induced infarct volume and neurological deficits in rats. Bioinformatics analysis revealed that PTEN was a miR-130a target and could overturn the effect of miR-130a on cerebral ischemia, both in vivo and in vitro. Therefore, we set out to further investigate the PTEN-affected PI3K/AKT pathway and found that upregulation of miR-130a activated the PI3K/AKT pathway.
Conclusions:
Our data demonstrated that miR-130a prevented cerebral I/R damage by mediating the PTEN/PI3K/AKT axis. These preliminarily findings furthered our understanding of this mechanism and identified new potential therapeutic targets for ischemic stroke.
Insights
MicroRNA-130a (miR-130a) protects the brain from ischemia-reperfusion injury by targeting PTEN and activating the PI3K/AKT pathway. This finding offers a potential therapeutic strategy for ischemic stroke.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Dysfunctional miRNA networks significantly impact ischemic stroke outcomes.
- Reduced miR-130a expression is linked to ischemic stroke development.
- Investigating miR-130a's neuroprotective mechanisms in ischemia-reperfusion (I/R) injury is crucial.
Purpose of the Study:
- To elucidate the mechanism of miR-130a-mediated neuroprotection against I/R injury.
- To identify the molecular targets of miR-130a in the context of cerebral ischemia.
- To explore the therapeutic potential of modulating miR-130a in ischemic stroke.
Main Methods:
- Utilized oxygen-glucose deprivation/reperfusion (OGDR) and middle cerebral artery occlusion (MCAO) models.
- Assessed gene and protein expression via RT-PCR and immunoblotting.
- Evaluated cell viability, apoptosis, ROS production, infarct volume, and neurological deficits.
- Employed bioinformatics, luciferase reporter assays, and pathway analysis (PTEN/PI3K/AKT).
Main Results:
- miR-130a expression was downregulated in both in vitro (OGDR) and in vivo (MCAO) models of cerebral ischemia.
- Overexpression of miR-130a enhanced cell survival, reduced apoptosis and ROS production, decreased infarct volume, and improved neurological function.
- PTEN was identified as a direct target of miR-130a, and its inhibition reversed miR-130a's protective effects.
- Upregulation of miR-130a activated the PI3K/AKT pathway by inhibiting PTEN.
Conclusions:
- miR-130a confers neuroprotection against cerebral I/R injury by targeting PTEN and modulating the PTEN/PI3K/AKT signaling axis.
- These findings enhance the understanding of molecular mechanisms underlying ischemic stroke.
- miR-130a represents a promising therapeutic target for managing ischemic stroke.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Other Glycolytic Pathways
Respiration Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...

